ESC 365 - What constitutes optimal pharmacotherapy and when OMT should be considered failed?

Open Access

What constitutes optimal pharmacotherapy and when OMT should be considered failed?

Session: Optimal medical treatment of chronic coronary syndromes CCS from the old model to a new combination approach

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Speaker: Doctor R. Al-Lamee (London, GB)

Sponsored by Servier

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Rasha Al-Lamee

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

23 presentations

6 followers

5 more presentations in this session

Introduction.

Speaker: Professor G. Rosano (London, GB)

Clinical evidence from real-world studies on benefits of the early combination of metabolic and hemodynamic approaches.

Speaker: Doctor L. Gowdak (Sao Paulo, BR)

Toward a combination approach in CCS: clinical rationale and patients' needs.

Speaker: Professor F. Pinto (Lisbon, PT)

Q&A.

Conclusion.

Speaker: Professor M. Marzilli (Pisa, IT)

Access the full session

Optimal medical treatment of chronic coronary syndromes CCS from the old model to a new combination approach

Speakers: Doctor R. Al-Lamee, Professor G. Rosano, Doctor L. Gowdak, Professor F. Pinto, Professor M. Marzilli

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources